3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
8
Other
2
NET
2
Endocrine
2
CNS
2
Thoracic
1
Sarcoma
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Breast
1
Conditions
Ovarian Neoplasms
805
Uterine Cervical Neoplasms
409
Fallopian Tube Neoplasms
289
Endometrial Neoplasms
287
Carcinoma, Ovarian Epithelial
252
Neoplasms
95
Recurrence
83
Breast Neoplasms
82
Peritoneal Neoplasms
66
Uterine Neoplasms
55
Colorectal Neoplasms
54
Uterine Cervical Dysplasia
50
Sarcoma
49
Vulvar Neoplasms
47
Neoplasm Metastasis
44
Carcinoma, Non-Small-Cell Lung
44
Stomach Neoplasms
42
Pancreatic Neoplasms
36
Melanoma
34
Testicular Neoplasms
32
Lung Neoplasms
32
Vaginal Neoplasms
28
Prostatic Neoplasms
28
Papillomavirus Infections
25
Carcinoma
25
Head and Neck Neoplasms
23
Esophageal Neoplasms
23
Carcinoma, Renal Cell
23
Urinary Bladder Neoplasms
21
Small Cell Lung Carcinoma
21
Interventions
alectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Intestinal Diseases
×
Gynecologic
×
Clear all
NCT04644315
2023-08-07
ALpha-T
Hoffmann-La Roche
Phase 2
Terminated
1 enrolled
5 charts